|
|
Dr. Lin is Vice President - Strategic Partnerships at Caris Life Sciences. Prior to her role at Caris, she was an Executive Director at Boehringer Ingelheim's Venture Fund. Having spent over 14 years at Boehringer Ingelheim, Dr. Lin held various roles in the US and internationally, including leading US digital healthcare efforts and investments, board directorship, and in global strategy and corporate development, and supporting drug launches in field-based roles in Health Economics and Medical Affairs.
She has earned a reputation as an executive deeply passionate and committed to steering her organization in new business strategy and development, intrapreneurial and strategic thinking, and executional excellence. She is an empathetic and dynamic leader who takes pride in helping to transform large organizations and pushing the envelope in new business strategies. A Life Science & Digital Health Investor and Pharmaceutical Executive, Dr. Lin is also committed to supporting women and minorities in science and leadership.
Dr. Lin holds a Ph.D. in Pharmacogenomics and Bioinformatics from the University of California San Francisco, a BS in Chemistry and Public Policy from Pomona College, and an MSc. Eng. from Stanford University School of Engineering.
She has earned a reputation as an executive deeply passionate and committed to steering her organization in new business strategy and development, intrapreneurial and strategic thinking, and executional excellence. She is an empathetic and dynamic leader who takes pride in helping to transform large organizations and pushing the envelope in new business strategies. A Life Science & Digital Health Investor and Pharmaceutical Executive, Dr. Lin is also committed to supporting women and minorities in science and leadership.
Dr. Lin holds a Ph.D. in Pharmacogenomics and Bioinformatics from the University of California San Francisco, a BS in Chemistry and Public Policy from Pomona College, and an MSc. Eng. from Stanford University School of Engineering.
